Mark Y Chan Selected Research

Mark Y Chan Research Topics

Disease

28	Myocardial Infarction 06/2022 - 01/2007
25	ST Elevation Myocardial Infarction 06/2022 - 04/2007
17	Thrombosis (Thrombus) 04/2022 - 04/2007
13	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022 - 06/2008
11	Hemorrhage 09/2022 - 08/2010
11	Acute Coronary Syndrome 01/2021 - 12/2010
9	Heart Failure 09/2022 - 01/2015
9	Stroke (Strokes) 04/2022 - 06/2010
6	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 09/2005
5	Infarction (Infarctions) 06/2022 - 05/2014
4	Reperfusion Injury 10/2020 - 05/2014
3	Atrial Fibrillation 09/2022 - 12/2012
3	Ventricular Remodeling 01/2021 - 07/2019
3	Inflammation (Inflammations) 01/2021 - 12/2012
3	Pathologic Constriction (Stenosis) 06/2015 - 08/2008
2	Cicatrix (Scar) 06/2022 - 10/2019
2	Death (Near-Death Experience) 04/2022 - 04/2018
2	Ischemic Stroke 01/2022 - 10/2021
2	Thrombocytopenia (Thrombopenia) 01/2022 - 02/2008
2	Neoplasms (Cancer) 10/2021 - 01/2021
2	Coronary Disease (Coronary Heart Disease) 10/2020 - 11/2008
2	Diabetes Mellitus 11/2018 - 01/2015
1	Cognitive Dysfunction 09/2022
1	Atherosclerotic Plaque (Atheroma) 01/2022
1	COVID-19 01/2022
1	Chronic Renal Insufficiency 01/2022
1	Type 2 Diabetes Mellitus (MODY) 01/2022
1	Dyslipidemias (Dyslipidemia) 01/2022
1	Weight Loss (Weight Reduction) 01/2022
1	Out-of-Hospital Cardiac Arrest 11/2021
1	Infections 01/2021
1	Pancreatic Diseases (Pancreatic Disease) 12/2020
1	Ventricular Dysfunction 12/2020
1	Heart Arrest (Cardiac Arrest) 11/2019

Drug/Important Bio-Agent (IBA)

13	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2015
11	Clopidogrel (Plavix)FDA Link 06/2022 - 06/2008
6	AnticoagulantsIBA 09/2022 - 02/2008
6	TicagrelorIBA 06/2022 - 05/2016
5	Pharmaceutical PreparationsIBA 01/2022 - 02/2008
5	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 11/2021 - 06/2008
4	omega-Chloroacetophenone (Mace)IBA 01/2022 - 07/2013
4	PolymersIBA 01/2022 - 04/2007
3	MicroRNAs (MicroRNA)IBA 10/2020 - 01/2017
3	Everolimus FDA Link 07/2016 - 08/2013
3	Prasugrel Hydrochloride FDA Link 05/2016 - 11/2012
2	Warfarin (Coumadin)FDA LinkGeneric 09/2022 - 12/2012
2	LipidsIBA 01/2022 - 10/2021
2	CeramidesIBA 01/2022 - 04/2018
2	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2022 - 01/2022
2	bivalirudin (Angiomax)FDA Link 11/2021 - 01/2017
2	CholesterolIBA 10/2021 - 01/2012
2	HDL CholesterolIBA 10/2021 - 01/2012
2	Thromboplastin (Tissue Factor)IBA 01/2021 - 10/2009
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 12/2012
2	Blood Proteins (Serum Proteins)IBA 10/2020 - 12/2012
2	Purinergic P2Y Receptor AntagonistsIBA 08/2020 - 01/2018
2	CreatinineIBA 11/2019 - 11/2008
2	pro-brain natriuretic peptide (1-76)IBA 10/2019 - 07/2017
2	Sirolimus (Rapamycin)FDA Link 01/2019 - 04/2007
2	erucylphosphocholineIBA 01/2019 - 07/2011
2	Phenobarbital (Luminal)FDA Link 06/2015 - 07/2011
2	MetalsIBA 01/2015 - 06/2010
2	Factor IXa (Coagulation Factor IXa)IBA 12/2009 - 06/2008
1	Vitamin K FDA Link 09/2022
1	GadoliniumIBA 06/2022
1	Thrombin FDA Link 06/2022
1	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 04/2022
1	Polysaccharides (Glycans)IBA 01/2022
1	Uric Acid (Urate)IBA 01/2022
1	VaccinesIBA 01/2022
1	Fibrinogen (Factor I)FDA Link 01/2022
1	Glucose (Dextrose)FDA LinkGeneric 01/2022
1	fibrin fragment D (D-dimer)IBA 01/2022
1	SodiumIBA 01/2022
1	LDL CholesterolIBA 10/2021
1	Triglycerides (Triacylglycerol)IBA 10/2021
1	oxidized low density lipoproteinIBA 10/2021
1	Omeprazole (Prilosec)FDA LinkGeneric 10/2021
1	CalciumIBA 10/2021
1	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2021
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2021
1	EnzymesIBA 12/2020
1	chenodeoxycholate sulfate conjugate (CDCS)IBA 10/2020
1	Dihydrotachysterol (AT 10)IBA 10/2020
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2020
1	Angiotensin Receptor AntagonistsIBA 01/2020
1	LDL Lipoproteins (beta Lipoproteins)IBA 12/2019
1	TroponinIBA 11/2019
1	Hemoglobins (Hemoglobin)IBA 11/2019
1	CollagenIBA 10/2019
1	Tissue Inhibitor of Metalloproteinase-1IBA 10/2019

Therapy/Procedure

28	Percutaneous Coronary Intervention 06/2022 - 04/2007
15	Stents 04/2022 - 04/2007
15	Therapeutics 11/2021 - 02/2008
9	Drug-Eluting Stents 01/2022 - 01/2007
5	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2022 - 08/2008
2	Patient Readmission 01/2019 - 01/2018
2	Secondary Prevention 01/2016 - 02/2008
1	Length of Stay 09/2022
1	Resuscitation 11/2021